• Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson to retire, Effective December 31, 2021

    Tuesday October 12th 2021

  • Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

    Tuesday October 12th 2021

  • Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

    Tuesday October 12th 2021

  • X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership

    Tuesday October 12th 2021

  • KU Leuven develops very potent antiviral against dengue

    Thursday October 7th 2021

  • Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer

    Wednesday October 6th 2021

  • atbtherapeutics expands leadership team and Scientific Advisory Board with pharmaceutical industry experts

    Wednesday October 6th 2021

  • New Flanders360 platform puts Flanders’ life sciences & health ecosystem on the international map

    Tuesday October 5th 2021

  • Your news here?

  • Second edition Medical Solutions Accelerator starts successfully

    Monday October 4th 2021

  • Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease

    Monday October 4th 2021

  • Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

    Monday October 4th 2021


Strategic Partners